Page 1426 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

71. McNelis J, Marini CP, Simms HH. Abdominal compartment 91. Koffler A, Friedler RM, Massry SG. Acute renal failure due to
syndrome: clinical manifestations and predictive factors. Curr non-traumatic rhabdomyolysis. Ann Intern Med. 1976;85:23.
Opin Crit Care. 2003;9:133. 92. Miller PD, Krebs RA, Neal BJ, McIntyre DO. Polyuric prerenal
72. Murray PT, Le Gall JR, Dos Reis Miranda D, et al. Physiologic failure. Ann Intern Med. 1980;140:907.
endpoints (efficacy) for acute renal failure studies. Curr Opin 93. Miller TR, Anderson RJ, Linas SL, et al. Urinary diagnostic indi-
Crit Care. 2002;8:519. ces in acute renal failure: a prospective study. Ann Intern Med.
73. Corrigan G, Ramaswamy D, Kwon O, et al. PAH extraction and 1978;89:47.
estimation of plasma flow in human post-ischemic acute renal 94. Pru C, Kjellstrand CM. The FENa test is of no prognostic value
failure. Am J Physiol. 1999;277(2 Pt 2):F312. in acute renal failure. Nephron. 1984;36:20.
74. Moran SM, Myers BD. Course of acute renal failure studied by 95. Goldstein MH, Lenz PR, Levitt MF. Effect of urine flow rate
a model of creatinine kinetics. Kidney Int. 1985;27(6):928-937. on urea reabsorption in man: urea as a ‘tubular marker’. J Appl
75. Erley CM, Bader BD, Berger ED, et al. Plasma clearance of Physiol. 1969;26:594.
iodine contrast media as a measure of glomerular filtration rate 96. Kelton J, Kelley WH, Holmes EW. A rapid method for the diagno-
in critically ill patients. Crit Care Med. 2001;29:1544. sis of acute uric acid nephropathy. Arch Intern Med. 1978;138:612.
76. Sladen RN, Endo E, Harrison T. Two-hour versus 22-hour creati- 97. Perazella M, Coca S, Kanbay M, et al. Diagnostic value of urine
nine clearance in critically ill patients. Anesthesiology. 1987;67:1013.
microscopy for differential diagnosis of acute kidney injury in
77. Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin hospitalized patients. Clin J Am Soc Nephrol. 2008;3:1615-1619.
C measured by automated immunoassay: a more sensitive 98. Murray PT, Mehta RL, Shaw AD, et al. Current use of biomark-
marker of changes in GFR than serum creatinine. Kidney Int. ers in Acute Kidney Injury: Report and summary of recom-
1995;47:312.
mendations from the 10th Acute Dialysis Quality Initiative
78. Massey D. Commentary: clinical diagnostic use of cystatin C. Consensus Conference. Kidney International, 2013; Oct 9, epub
J Clin Lab Analysis. 2004;18:55. ahead of print.
79. Laterza OF, Price CP, Scott MG. Cystatin C: an improved esti- 99. Singer E, Elger A, Elitok S, et al. Urinary neutrophil gelatinase-
mator of glomerular filtration rate? Clin Chem. 2002;48:699. associated lipocalin distinguishes pre-renal from intrinsic renal
80. Rickli H, Benou K, Ammann P, et al. Time course of serial cys- failure and predicts outcomes. Kidney Int. 2011;80:405-414.
tatin levels in comparison with serum creatinine after applica- 100. Nickolas TL, O’Rourke MJ, Yang J, et al. Sensitivity and specific-
tion of radiocontrast media. Clin Nephrol. 2004;61:98. ity of a single emergency department measurement of urinary
81. Christensson A, Ekberg J, Grubb A, et al. Serum cystatin C is a neutrophil gelatinase-associated lipocalin for diagnosing acute
more sensitive and more accurate marker of glomerular filtra- kidney injury. Ann Intern Med. 2008;148(11):810-819.
tion rate than enzymatic measurements of creatinine in renal 101. Nickolas TL, Schmitt-Ott KM, Canetta P, et al. Diagnostic and
transplantation. Nephron Physiol. 2003;94:19. prognostic stratification in the emergency department using
82. Le Bricon T, Thervet E, Benlakehal M, et al. Changes in plasma urinary biomarkers of nephron damage: a multicenter prospec-
cystatin C after renal transplantation and acute rejection in tive study. J Am Coll Cardiol. 2012;59(3);246-255.
adults. Clin Chem. 1999;45:2243. 102. Okusa MD, Jaber BL, Doran P, et al. Physiological biomarkers
83. Orlando R, Mussap M, Plebani M, et al. Diagnostic value of of acute kidney injury: a conceptual approach to improving
plasma cystatin C as a glomerular filtration marker in decom- outcomes. Contrib Nephrol. 2013;182:65-81.
pensated liver cirrhosis. Clin Chem. 2002;48:850. 103. Maillet PJ. Nondilated obstructive acute renal failure: diag-
84. Gunther A, Burchard GD, Slevogt H, et al. Renal dysfunction nostic procedures and therapeutic management. Radiology.
in falciparum-malaria is detected more often when assessed by 1986;160:659.
serum concentration of cystatin C instead of creatinine. Trop 104. Davidson MB, Thakkar S, Hix JK, et al. Pathophysiology, clini-
Med Int Health. 2002;7:931. cal consequences, and treatment of tumor lysis syndrome. Am J
85. Delanaye P, Lambermont B, Chapelle JP, et al. Plasmatic cystatin Med. 2004;116:546.
C for the estimation of glomerular filtration rate in intensive 105. Conger JD, Falk SA. Intrarenal dynamics in the pathogen-
care units. Intensive Care Med. 2004;30:980. esis and prevention of acute urate nephropathy. J Clin Invest.
86. Herget-Rosenthal S, Marggraf G, Husing G, et al. Early detec- 1977;59:786.
tion of acute renal failure by serum cystatin C. Kidney Int. 106. Robinson RR, Yarger WE. Acute uric acid nephropathy (edito-
2004;66:1115. rial). Arch Intern Med. 1977;137:839.
87. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the 107. Goldman SC, Holcenberg JS, Finklestein JZ, et al. A ran-
fractional excretion of urea in the differential diagnosis of acute domized comparison between rasburicase and allopurinol in
renal failure. Kidney Int. 2002;62:2223. children with lymphoma and leukemia at high risk for tumor
88. Dagher PC, Herget-Rosenthal S, Ruehm SG, et al. Newly devel- lysis. Blood. 2001;97:2998.
oped techniques to study and diagnose acute renal failure. J Am 108. Kaplan BS, Hebert D, Morrell RE. Acute renal failure induced by
Soc Nephrol. 2003;14:2188. hyperphosphatemia in acute lymphoblastic leukemia. Can Med
89. Han WK, Bailly V, Abichandani R, et al. Kidney injury Assoc J. 1981;124:429.
molecule-1 (KIM-1): a novel biomarker for human renal proxi- 109. Agha-Razii M, Amyot SL, Pichette V, et al. Continuous venove-
mal tubule injury. Kidney Int. 2002;62:237. nous hemodiafiltration for the treatment of spontaneous tumor
90. McGee S, Abernethy WB 3rd, Simel DL. The rational clinical lysis syndrome complicated by acute renal failure and severe
examination: is this patient hypovolemic? JAMA. 1999;281:1022. hyperuricemia. Clin Nephrol. 2000;54:59.

Section08-O-Ref.indd 3 12/10/2014 6:08:07 PM